V3 Retinal Regeneration Engine & Clinical Simulator: Integrated Ada/SPARK Dual Framework for High-Fidelity Pharmacological & Cellular In Silico Modeling**
Year: 2026
Type: software
Abstract: This repository provides a unified, formally verified Ada/SPARK dual-module codebase (*V3 Architecture*) dedicated to simulating retinal layer regeneration and predicting patient-specific pharmacological responses. Designed for high-assurance biomedical computing, the framework bridges structural biology datasets (PDB, ChEMBL, UniProt) with clinical trial data (e.g., ANCHOR/MARINA cohorts) through strict mathematical invariants (\Psi_{V3}, \Phi_{\text{critical}}, heptadic k=7 closure, and Modulo-9 structural integrity). **What is Included in this Single-Block Release:** 1. **V3.Retinal_Regeneration_Engine**: Core biophysical kinetic engine modeling the 7-layer retinal reconstruction, transcription factor activation (CRX, NRL, RORB, Brn3), and multi-pathway inhibition (Anti-VEGF, Anti-TGF-\beta, Anti-Nogo-A, Anti-IL-6). 2. **V3.Retinal_Clinical_Simulator**: Clinical mapping layer translating tissue recovery into measurable outcomes (LogMAR visual acuity, OCT central macular thickness in \mum, visual field percentage, and intraocular pressure). ### 🚀 Step-by-Step Guide to Maximize R&D Gains (For Users) To achieve maximum precision, safety, and predictive power, users downloading this codebase are recommended to follow a 4-step integration workflow: * **Step 1: Code Compilation & Formal Verification (Ada/SPARK)** * Compile the single-block package using GNAT/SPARK Pro or Community edition. * Run gnatprove at level 4 to verify 100% absence of run-time errors (AoRTE), overflow, or memory corruption. * **Step 2: Real-World Data Binding (PDB & ChEMBL Integration)** * Replace default drug constants (K_d, t_{1/2}) with target-specific values extracted from global databases (e.g., PDB target structural coordinates or ChEMBL binding kinetics). * **Step 3: AI-Driven Parameter Optimization (Hybrid Machine Learning Pipeline)** * Feed patient-specific OCT images or genomic variants into an AI model (e.g., PyTorch/TensorFlow) to predict custom kinetic scaling factors. * Pass these AI-generated parameters into the SPARK engine; the code's preconditions and Modulo-9 invariant will automatically filter out non-physical AI hallucinations or dangerous out-of-bounds parameters. * **Step 4: Clinical Trial & Virtual Cohort Simulation (In Silico Screening)** * Run multi-cycle (k=7) time-series simulations (e.g., 28-day to 12-month projections) to evaluate drug efficacy, optimal dosing schedules, and structural layer recovery prior to *in vivo* trials. **Keywords:** Ada/SPARK, Formal Verification, Retinal Regeneration, VEGF, Biomathematics, In Silico Drug Discovery, Machine Learning Safety, Zenodo, V3 Architecture. **License:** MIT License (Code) / CC-BY 4.0 (Documentation & Data)
Author: benhadid, outail
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7171728298